fiteBac SkinCare Germicidal Hand Softening Gel a Hand Sanitizer Breakthrough Technology

Marietta, GA (PRWEB) December 13, 2011

fiteBac SkinCare, LLC, a subsidiary of Kimmerling Holdings Group, LLC (KHG), a Georgia-based biotech company that has developed an antimicrobial intellectual property platform technology, has announced that it has launched what it expects will be a new standard in hand hygiene, fiteBac SkinCare Germicidal Hand Softening Gel. The Company is excited that it has brought to market an innovative hand sanitizer that is skin friendly and will encourage hand hygiene compliance among healthcare professionals, which will help in the effort to reduce healthcare associated infections, a huge burden on patient health, life and healthcare costs.

The key to the fiteBac Gel is its patent pending technology that is comprised of a unique combination of a non-alcohol based antimicrobial formulation, together with a silicone-based cross polymer that provides hydrophobic properties that improve the skins moisture barrier and keep the skin velvety soft, even after frequent hand washing or glove use. fiteBac SkinCare believes its technology will help reverse the trend of skin damage associated with frequent use of soaps and traditional sanitizers. The fiteBac Gel is paraffin-free, water-free, unscented, petroleum-free, and alcohol free. The vision of the inventor, former Dow Corning chemist, John Blizzard, was to create a sanitizer without the harmful side effects linked to other traditional hand sanitizers.